• 473 Citations
  • 8 h-Index
20062019
If you made any changes in Pure these will be visible here soon.

Research Output 2006 2019

  • 473 Citations
  • 8 h-Index
  • 30 Article
  • 1 Letter
Filter
Article
2019

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

Efficace, F., Stagno, F., Iurlo, A., Breccia, M., Cottone, F., Bonifacio, M., Abruzzese, E., Castagnetti, F., Caocci, G., Crugnola, M., Capodanno, I., Martino, B., Tiribelli, M., Patriarca, A., Gozzini, A., Pregno, P., Saussele, S., Cascavilla, N., Fozza, C., Bergamaschi, M. & 3 others, Binotto, G., Vignetti, M. & Rosti, G., 2019, In : Leukemia.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Quality of Life
Confidence Intervals
Protein-Tyrosine Kinases
Therapeutics

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

Efficace, F., Stagno, F., Iurlo, A., Breccia, M., Cottone, F., Bonifacio, M., Abruzzese, E., Castagnetti, F., Caocci, G., Crugnola, M., Capodanno, I., Martino, B., Tiribelli, M., Patriarca, A., Gozzini, A., Pregno, P., Saussele, S., Cascavilla, N., Fozza, C., Bergamaschi, M. & 3 others, Binotto, G., Vignetti, M. & Rosti, G., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Quality of Life
Confidence Intervals
Protein-Tyrosine Kinases
Therapeutics

Home care of acute leukaemia patients: From active therapy to end-of-life and palliative care. The 3-year experience of a single centre

Capodanno, I., Tamagnini, E., Alfieri, P., Codeluppi, K., Luminari, S. & Merli, F., Jan 1 2019, In : European Journal of Haematology.

Research output: Contribution to journalArticle

Terminal Care
Home Care Services
Palliative Care
Leukemia
Hospitalization

Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice

Fava, C., Rege-Cambrin, G., Dogliotti, I., Cerrano, M., Berchialla, P., Dragani, M., Rosti, G., Castagnetti, F., Gugliotta, G., Martino, B., Gambacorti-Passerini, C., Abruzzese, E., Elena, C., Pregno, P., Gozzini, A., Capodanno, I., Bergamaschi, M., Crugnola, M., Bocchia, M., Galimberti, S. & 25 others, Rapezzi, D., Iurlo, A., Cattaneo, D., Latagliata, R., Breccia, M., Cedrone, M., Santoro, M., Annunziata, M., Levato, L., Stagno, F., Cavazzini, F., Sgherza, N., Giai, V., Luciano, L., Russo, S., Musto, P., Caocci, G., Sorà, F., Iuliano, F., Lunghi, F., Specchia, G., Pane, F., Ferrero, D., Baccarani, M. & Saglio, G., 2019, In : Haematologica. 104, 8, p. 1589-1596 8 p.

Research output: Contribution to journalArticle

Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice

Fava, C., Rege-Cambrin, G., Dogliotti, I., Cerrano, M., Berchialla, P., Dragani, M., Rosti, G., Castagnetti, F., Gugliotta, G., Martino, B., Gambacorti-Passerini, C., Abruzzese, E., Elena, C., Pregno, P., Gozzini, A., Capodanno, I., Bergamaschi, M., Crugnola, M., Bocchia, M., Galimberti, S. & 25 others, Rapezzi, D., Iurlo, A., Cattaneo, D., Latagliata, R., Breccia, M., Cedrone, M., Santoro, M., Annunziata, M., Levato, L., Stagno, F., Cavazzini, F., Sgherza, N., Giai, V., Luciano, L., Russo, S., Musto, P., Caocci, G., Sorà, F., Iuliano, F., Lunghi, F., Specchia, G., Pane, F., Ferrero, D., Baccarani, M. & Saglio, G., 2019, In : Haematologica. 104, 8, p. 1589-1596 8 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice

Fava, C., Rege-Cambrin, G., Dogliotti, I., Cerrano, M., Berchialla, P., Dragani, M., Rosti, G., Castagnetti, F., Gugliotta, G., Martino, B., Gambacorti-Passerini, C., Abruzzese, E., Elena, C., Pregno, P., Gozzini, A., Capodanno, I., Bergamaschi, M., Crugnola, M., Bocchia, M., Galimberti, S. & 25 others, Rapezzi, D., Iurlo, A., Cattaneo, D., Latagliata, R., Breccia, M., Cedrone, M., Santoro, M., Annunziata, M., Levato, L., Stagno, F., Cavazzini, F., Sgherza, N., Giai, V., Luciano, L., Russo, S., Musto, P., Caocci, G., Sorà, F., Iuliano, F., Lunghi, F., Specchia, G., Pane, F., Ferrero, D., Baccarani, M. & Saglio, G., Jul 31 2019, In : Haematologica. 104, 8, p. 1589-1596 8 p.

Research output: Contribution to journalArticle

Open Access
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Observational Studies
Therapeutics
Leukemia, Myeloid, Chronic Phase

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

Fava, C., Rege-Cambrin, G., Dogliotti, I., Cerrano, M., Berchialla, P., Dragani, M., Rosti, G., Castagnetti, F., Gugliotta, G., Martino, B., Gambacorti-Passerini, C., Abruzzese, E., Elena, C., Pregno, P., Gozzini, A., Capodanno, I., Bergamaschi, M., Crugnola, M., Bocchia, M., Galimberti, S. & 25 others, Rapezzi, D., Iurlo, A., Cattaneo, D., Latagliata, R., Breccia, M., Cedrone, M., Santoro, M., Annunziata, M., Levato, L., Stagno, F., Cavazzini, F., Sgherza, N., Giai, V., Luciano, L., Russo, S., Musto, P., Caocci, G., Sorà, F., Iuliano, F., Lunghi, F., Specchia, G., Pane, F., Ferrero, D., Baccarani, M. & Saglio, G., Aug 2019, In : Haematologica. 104, 8, p. 1589-1596 8 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Observational Studies
Therapeutics
Leukemia, Myeloid, Chronic Phase

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

Crugnola, M., Castagnetti, F., Breccia, M., Ferrero, D., Trawinska, M. M., Abruzzese, E., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Bonifacio, M., Fava, C., Iurlo, A., Bucelli, C., Mansueto, G., Gozzini, A., Falzetti, F., Montefusco, E., Crisà, E., Gugliotta, G. & 24 others, Russo, S., Cedrone, M., RussoRossi, A., Pregno, P., Isidori, A., Mauro, E., Atelda, R., Giglio, G., Celesti, F., Sorà, F., Storti, S., D’Addosio, A., Galimberti, S., Orlandi, E., Calistri, E., Bocchia, M., Cavazzini, F., Rege Cambrin, G., Orofino, N., Luciano, L., Sgherza, N., Rosti, G., Latagliata, R. & Capodanno, I., 2019, In : Annals of Hematology.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Cytogenetics
Disease-Free Survival
Germany

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

Crugnola, M., Castagnetti, F., Breccia, M., Ferrero, D., Trawinska, M. M., Abruzzese, E., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Bonifacio, M., Fava, C., Iurlo, A., Bucelli, C., Mansueto, G., Gozzini, A., Falzetti, F., Montefusco, E., Crisà, E., Gugliotta, G. & 24 others, Russo, S., Cedrone, M., RussoRossi, A., Pregno, P., Isidori, A., Mauro, E., Atelda, R., Giglio, G., Celesti, F., Sorà, F., Storti, S., D'Addosio, A., Galimberti, S., Orlandi, E., Calistri, E., Bocchia, M., Cavazzini, F., Rege Cambrin, G., Orofino, N., Luciano, L., Sgherza, N., Rosti, G., Latagliata, R. & Capodanno, I., Oct 2019, In : Annals of Hematology. 98, 10, p. 2329-2338 10 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Cytogenetics
Disease-Free Survival
Disease Progression

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

Crugnola, M., Castagnetti, F., Breccia, M., Ferrero, D., Trawinska, M. M., Abruzzese, E., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Bonifacio, M., Fava, C., Iurlo, A., Bucelli, C., Mansueto, G., Gozzini, A., Falzetti, F., Montefusco, E., Crisà, E., Gugliotta, G. & 24 others, Russo, S., Cedrone, M., RussoRossi, A., Pregno, P., Isidori, A., Mauro, E., Atelda, R., Giglio, G., Celesti, F., Sorà, F., Storti, S., D’Addosio, A., Galimberti, S., Orlandi, E., Calistri, E., Bocchia, M., Cavazzini, F., Rege Cambrin, G., Orofino, N., Luciano, L., Sgherza, N., Rosti, G., Latagliata, R. & Capodanno, I., Jan 1 2019, In : Annals of Hematology. 98, 10, p. 2329-2338

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Cytogenetics
Disease-Free Survival
Disease Progression
2018

Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome

Sora, F., Iurlo, A., Sica, S., Latagliata, R., Annunziata, M., Galimberti, S., Castagnetti, F., Pregno, P., Sgherza, N., Celesti, F., Bocchia, M., Gozzini, A., Fava, C., Cattaneo, D., Crugnola, M., Montefusco, E., Mauro, E., Capodanno, I. & Breccia, M., 2018, In : British Journal of Haematology. 181, 2, p. 267-270 4 p.

Research output: Contribution to journalArticle

Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib

Efficace, F., Castagnetti, F., Martino, B., Breccia, M., D'Adda, M., Angelucci, E., Stagno, F., Cottone, F., Malato, A., Trabacchi, E., Capalbo, S. F., Gobbi, M., Visani, G., Salvucci, M., Capodanno, I., Tosi, P., Tiribelli, M., Scortechini, A. R., Levato, L., Maino, E. & 5 others, Binotto, G., Gugliotta, G., Vignetti, M., Baccarani, M. & Rosti, G., May 15 2018, In : Cancer. 124, 10, p. 2228-2237 10 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Quality of Life
Fatigue
Therapeutics
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
3 Citations (Scopus)

Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib

Efficace, F., Castagnetti, F., Martino, B., Breccia, M., D'Adda, M., Angelucci, E., Stagno, F., Cottone, F., Malato, A., Trabacchi, E., Capalbo, S. F., Gobbi, M., Visani, G., Salvucci, M., Capodanno, I., Tosi, P., Tiribelli, M., Scortechini, A. R., Levato, L., Maino, E. & 5 others, Binotto, G., Gugliotta, G., Vignetti, M., Baccarani, M. & Rosti, G., May 15 2018, In : Cancer. 124, 10, p. 2228-2237 10 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Quality of Life
Fatigue
Therapeutics
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
4 Citations (Scopus)

Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice

Breccia, M., Abruzzese, E., Castagnetti, F., Bonifacio, M., Gangemi, D., Sorà, F., Iurlo, A., Luciano, L., Gozzini, A., Gentile, M., Bocchia, M., Luzi, D., Maggi, A., Sgherza, N., Isidori, A., Crugnola, M., Pregno, P., Scortechini, A. R., Capodanno, I., Pizzuti, M. & 1 others, Foà, R., 2018, In : Annals of Hematology. 97, 9, p. 1577-1580 4 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Therapeutics
ponatinib
Protein-Tyrosine Kinases

Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice

Breccia, M., Abruzzese, E., Castagnetti, F., Bonifacio, M., Gangemi, D., Sorà, F., Iurlo, A., Luciano, L., Gozzini, A., Gentile, M., Bocchia, M., Luzi, D., Maggi, A., Sgherza, N., Isidori, A., Crugnola, M., Pregno, P., Scortechini, A. R., Capodanno, I., Pizzuti, M. & 1 others, Foà, R., Sep 2018, In : Annals of Hematology. 97, 9, p. 1577-1580 4 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Therapeutics
ponatinib
Protein-Tyrosine Kinases
2017
13 Citations (Scopus)

A population-based study of chronic myeloid leukemia patients treated with imatinib in first line

Castagnetti, F., Di Raimondo, F., Vivo, A. D., Spitaleri, A., Gugliotta, G., Fabbiano, F., Capodanno, I., Mannina, D., Salvucci, M., Antolino, A., Marasca, R., Musso, M., Crugnola, M., Impera, S., Trabacchi, E. E., Musolino, C., Cavazzini, F., Mineo, G., Tosi, P., Tomaselli, C. & 12 others, Rizzo, M., Siragusa, S., Fogli, M., Ragionieri, R., Zironi, A., Soverini, S., Martinelli, G., Cavo, M., Vigneri, P., Stagno, F., Rosti, G. & Baccarani, M., Jan 1 2017, In : American Journal of Hematology. 92, 1, p. 82-87 6 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Population
Survival
Leukemia
3 Citations (Scopus)

Chronic myeloid leukaemia with extreme thrombocytosis at presentation: Incidence, clinical findings and outcome

Sora', F., Iurlo, A., Sica, S., Latagliata, R., Annunziata, M., Sara, G., Castagnetti, F., Pregno, P., Sgherza, N., Celesti, F., Bocchia, M., Gozzini, A., Fava, C., Cattaneo, D., Monica, C., Montefusco, E., Mauro, E., Capodanno, I. & Breccia, M., 2017, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome

Sora, F., Iurlo, A., Sica, S., Latagliata, R., Annunziata, M., Galimberti, S., Castagnetti, F., Pregno, P., Sgherza, N., Celesti, F., Bocchia, M., Gozzini, A., Fava, C., Cattaneo, D., Crugnola, M., Montefusco, E., Mauro, E., Capodanno, I. & Breccia, M., Feb 7 2017, In : British Journal of Haematology.

Research output: Contribution to journalArticle

2016
7 Citations (Scopus)

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: Final results of a pilot phase II study

Federico, M., Luminari, S., Pellegrini, C., Merli, F., Pesce, E. A., Chauvie, S., Gandolfi, L., Capodanno, I., Salati, M., Argnani, L. & Zinzani, P. L., Mar 31 2016, In : Haematologica. 101, 4, p. e139-e141 3 p.

Research output: Contribution to journalArticle

Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia

Latagliata, R., Stagno, F., Annunziata, M., Abruzzese, E., Iurlo, A., Guarini, A., Fava, C., Gozzini, A., Bonifacio, M., Sorà, F., Leonetti Crescenzi, S., Bocchia, M., Crugnola, M., Castagnetti, F., Capodanno, I., Galimberti, S., Feo, C., Porrini, R., Pregno, P., Rizzo, M. & 11 others, Antolino, A., Mauro, E., Sgherza, N., Luciano, L., Tiribelli, M., Russo Rossi, A., Trawinska, M. M., Vigneri, P., Breccia, M., Rosti, G. & Alimena, G., Sep 1 2016, In : Neoplasia. 18, 9, p. 536-540 5 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Therapeutics
Comorbidity
Dasatinib
Leukemia, Myeloid, Chronic Phase

Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia

Latagliata, R., Stagno, F., Annunziata, M., Abruzzese, E., Iurlo, A., Guarini, A., Fava, C., Gozzini, A., Bonifacio, M., Sorà, F., Leonetti Crescenzi, S., Bocchia, M., Crugnola, M., Castagnetti, F., Capodanno, I., Galimberti, S., Feo, C., Porrini, R., Pregno, P., Rizzo, M. & 11 others, Antolino, A., Mauro, E., Sgherza, N., Luciano, L., Tiribelli, M., Russo Rossi, A., Trawinska, M. M., Vigneri, P., Breccia, M., Rosti, G. & Alimena, G., Sep 1 2016, In : Neoplasia. 18, 9, p. 536-540 5 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Therapeutics
Comorbidity
Dasatinib
Leukemia, Myeloid, Chronic Phase
8 Citations (Scopus)

Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia

Latagliata, R., Stagno, F., Annunziata, M., Abruzzese, E., Iurlo, A., Guarini, A., Fava, C., Gozzini, A., Bonifacio, M., Sorà, F., Leonetti Crescenzi, S., Bocchia, M., Crugnola, M., Castagnetti, F., Capodanno, I., Galimberti, S., Feo, C., Porrini, R., Pregno, P., Rizzo, M. & 11 others, Antolino, A., Mauro, E., Sgherza, N., Luciano, L., Tiribelli, M., Russo Rossi, A., Trawinska, M., Vigneri, P., Breccia, M., Rosti, G. & Alimena, G., Sep 1 2016, In : Neoplasia (United States). 18, 9, p. 536-540 5 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Therapeutics
Comorbidity
Dasatinib
Leukemia, Myeloid, Chronic Phase
2015
2 Citations (Scopus)

Anaplastic lymphoma kinase-positive large B-cell lymphoma: Description of a case with an unexpected clinical outcome

Zanelli, M., Valli, R., Capodanno, I., Ragazzi, M. & Ascani, S., Feb 13 2015, In : International Journal of Surgical Pathology. 23, 1, p. 78-83 6 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Stem Cell Transplantation
Lymphoid Tissue
L-Lactate Dehydrogenase
Cytogenetics
2014
39 Citations (Scopus)

Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: Results from a study of the Fondazione Italiana Linfomi

Merli, F., Luminari, S., Rossi, G., Mammi, C., Marcheselli, L., Ferrari, A., Spina, M., Tucci, A., Stelitano, C., Capodanno, I., Fragasso, A., Baldini, L., Bottelli, C., Montechiarello, E., Fogazzi, S., Lamorgese, C., Cavalli, L. & Federico, M., Jan 2014, In : Leukemia and Lymphoma. 55, 1, p. 38-43 6 p.

Research output: Contribution to journalArticle

Geriatric Assessment
Frail Elderly
Lymphoma, Large B-Cell, Diffuse
Survival
Combination Drug Therapy
16 Citations (Scopus)

Primary diffuse large B-cell lymphoma of the uterus: Case report and review

Mandato, V. D., Palermo, R., Falbo, A., Capodanno, I., Capodanno, F., Gelli, M. C., Aguzzoli, L., Abrate, M. & La Sala, G. B., Aug 1 2014, In : Anticancer Research. 34, 8, p. 4377-4390 14 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Uterus
Cervix Uteri
Myoma
Rare Diseases
2013
38 Citations (Scopus)

Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia

Latagliata, R., Breccia, M., Fava, C., Stagno, F., Tiribelli, M., Luciano, L., Gozzini, A., Gugliotta, G., Annunziata, M., Cavazzini, F., Ferrero, D., Musto, P., Capodanno, I., Iurlo, A., Visani, G., Crugnola, M., Calistri, E., Castagnetti, F., Vigneri, P. & Alimena, G., Jun 2013, In : Hematological Oncology. 31, 2, p. 363-369 7 p.

Research output: Contribution to journalArticle

Risk Management
Pleural Effusion
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Incidence
Therapeutics
2012
81 Citations (Scopus)

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi

Merli, F., Luminari, S., Ilariucci, F., Petrini, M., Visco, C., Ambrosetti, A., Stelitano, C., Caracciolo, F., di Renzo, N., Angrilli, F., Carella, A. M., Capodanno, I., Barbolini, E., Galimberti, S. & Federico, M., Feb 2012, In : British Journal of Haematology. 156, 3, p. 346-353 8 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cytarabine
Methotrexate
Multicenter Studies
Therapeutics
2011

An 89-year-old patient with "5q- syndrome": One of the oldest patients treated with lenalidomide. A case report

Capodanno, I. & Avanzini, P., Jul 2011, In : European Geriatric Medicine. 2, 3, p. 174-176 3 p.

Research output: Contribution to journalArticle

14 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Inflammation
Kidney
Lymphoma
Neoplasms
2006
237 Citations (Scopus)

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease

Gallamini, A., Rigacci, L., Merli, F., Nassi, L., Bosi, A., Capodanno, I., Luminari, S., Vitolo, U., Sancetta, R., Iannitto, E., Trentin, L., Stelitano, C., Tavera, S., Biggi, A., Castagnoli, A., Versari, A., Gregianin, M., Pelosi, E., Torchio, P. & Levis, A., Apr 2006, In : Haematologica. 91, 4, p. 475-481 7 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Positron-Emission Tomography
Drug Therapy
Therapeutics
Survival